JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
NBIX Financials - Neurocrine Biosciences Income & Cash Flow | Ledgeburg
NBIX - Neurocrine Biosciences Inc.
USD | NASDAQ | Healthcare
Summary
Summary NBIX Stock
Financials
Financials NBIX Stock
Loading...
Loading...
Income Statement
Income Statement NBIX Stock
Balance Sheet
Balance Sheet NBIX Stock
Cash Flow Statement
Cash Flow Statement NBIX Stock
Loading...
Loading...
Home
Stocks
Neurocrine Biosciences Inc. (NBIX)
Financials
Financials of NBIX
Loading...
Loading...
Loading...
Loading...
Revenue
$2.8605B
Operating Income
$619.1M
Net Income
$478.6M
Share Count (Basic)
99.5M
Operating Cash Flow
$782.7M
Free Cash Flow
$748.7M
Cash And Short-Term Equivalents
$713M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
1B
2B
3B
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
200M
400M
600M
800M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
0
100M
200M
300M
400M
500M
Annual
Quarterly
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
100%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26